Form 4: Inogen CCO's Stock Transactions Post RSU Vesting
Insider Transaction Report
Inogen's Chief Commercial Officer, Gregoire Ramade, reported the acquisition of common stock from restricted stock unit vesting and subsequent tax-related share disposition.
Summary
- Gregoire Ramade, Chief Commercial Officer of Inogen Inc., reported transactions on December 1, 2025.
- Acquired 31,566 shares of Inogen common stock upon the vesting of restricted stock units (RSUs).
- Disposed of 12,943 shares of common stock at a price of $6.95 per share to cover tax withholding liabilities related to the RSU vesting.
- Following these transactions, Ramade beneficially owns 37,246 shares of Inogen common stock.
- Ramade also holds 31,565 unvested restricted stock units.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The vesting of restricted stock units is a standard compensation event, indicating continued executive tenure and alignment. The tax-related sale is also standard practice. No significant positive or negative operational news is conveyed.
Positives
- Vesting of restricted stock units indicates continued service and alignment of executive interests with shareholders.
- The acquisition of 31,566 shares of common stock increases the executive's direct ownership in the company (prior to tax withholding).
Negatives
- Disposition of 12,943 shares for tax purposes reduces the executive's net beneficial ownership of common stock from the vested amount.
Future Outlook
The filing details a past transaction (vesting on December 1, 2025). It mentions a vesting schedule for restricted stock units (1/3rd annually from December 1, 2023), implying future vesting events if the executive continues service.
Industry Context
This Form 4 filing reports a routine insider transaction related to executive compensation, which is a standard compliance disclosure and does not typically provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The Chief Commercial Officer's increased direct ownership (post-tax sale) aligns their interests with shareholders. The sale for tax purposes is a routine event and does not indicate a lack of confidence.
- Employees: Continued executive tenure and compensation structure are reflected in the RSU vesting.
Next Steps
- Future vesting of remaining restricted stock units on subsequent annual anniversaries of December 1, 2023, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 12/01/2023 | Vesting Commencement Date for restricted stock units. |
| 12/01/2025 | Date of RSU vesting and related common stock transactions. |
| 12/02/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine executive compensation event involving the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations. Such transactions are standard and do not typically signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it provides no new information to warrant a change in investment recommendation based solely on this filing.
Keywords
Inogen Inc, INGN, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Gregoire Ramade, Chief Commercial Officer, Stock Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.